News

BioTime, has revealed its plan to organize a new subsidiary, BioTime Asia, for the purpose of clinically developing and marketing therapeutic stem cell products in the People’s Republic

Karnataka drug controller, Dr BR Jagashetty has asked to amend Drugs & Cosmetics Act to restrict the movement of not-of-standard quality and defective packaging drugs in the state.

Lundbeck, a wholly owned subsidiary of H Lundbeck in Denmark, has announced that Sabril (vigabatrin) tablets and powder for Oral Solution are now available for prescribing in the

AEterna Zentaris has announced the completion of a phase 1 study of orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma.

NovoStent has completed enrollment in the European clinical trial evaluating the use of SAMBATM Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease.

NanoViricides has signed a ‘Master Service Agreement’ with the Southern Research Institute (Southern Research), Birmingham. The agreement will allow Southern Research to perform testing of the company’s anti-Influenza

Altos Solutions and Oncology Metrics have planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will

San Diego-based Concerro has announced the launch of PanFluAware, an automated software solution and decision making system for H1N1 preparation and response. As the 2009/10 flu season begins,

Icagen has announced a one year extension to a prior collaboration and licensing agreement with Pfizer aimed at discovering, developing and commercializing compounds that modify three specific sodium